Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares MIR218-1, CT3001, Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours., Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors and the tag gi.
Shares Francisco Berrospi Espinoza, A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors, Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers, Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers and the tag gi.
Shares Ascentawits Pharmaceuticals, Francisco Berrospi Espinoza, SL-28 for Advanced Solid Tumours, Fiducial markers and the tag gi.
Shares Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers, 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer, A Study of MT-4561 in Patients With Various Advanced Solid Tumors, Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma and the tag gi.
Shares Mucositis and stomatitis, Hand-foot syndrome and hand-foot skin reaction, Peripheral neuropathy (chemotherapy-induced), Febrile neutropenia and the tag gi.
Shares Total neoadjuvant therapy (TNT, rectal cancer), Resection margins (R0 / R1 / R2), TNM staging, MRI and the tag gi.
Shares TNM staging, Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR), Minimal / molecular residual disease (MRD), Histopathology & immunohistochemistry and the tag gi.
Shares Wnt / β-catenin, RAS / RAF / MEK / ERK (MAPK), TP53, KRAS and the tag gi.
The same record for scripts and assistants; checked 2026-09-24. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.